Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

• Ana Carrizosa Anderson,
• Ernest C Borden,
• David Kaufman,
• Michael J Mastrangelo,
• David R Parkinson,
• Jon M Wiggington,
• Jeffrey S Weber

Affiliations

Ana Carrizosa Anderson

Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA

Ernest C Borden

Comprehensive Cancer Center, University of Wisconsin System, Madison, Wisconsin, USA

David Kaufman

Bill & Melinda Gates Medical Research Institute, Cambridge, Massachusetts, USA

Michael J Mastrangelo

Thomas Jefferson University, Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA

David R Parkinson

ESSA Pharma Inc, Palo Alto, California, USA

Jon M Wiggington

MacroGenics Inc, Rockville, Maryland, USA

Jeffrey S Weber

Laura and Isaac Perlmutter Comprehensive Cancer Center, NYU Langone Medical Center, New York, New York, USA